Results 161 to 170 of about 1,816 (199)
Some of the next articles are maybe not open access.
Expert Opinion on Pharmacotherapy, 2014
Diabetic macular edema (DME) can be treated with intravitreal glucocorticoids, particularly triamcinolone acetonide, dexamethasone (DEX), and fluocinolone acetonide (FA).The pathophysiology of DME includes multiple growth factors such as VEGF and also inflammatory mediators.
Thomas A Ciulla, Alon Harris
exaly +4 more sources
Diabetic macular edema (DME) can be treated with intravitreal glucocorticoids, particularly triamcinolone acetonide, dexamethasone (DEX), and fluocinolone acetonide (FA).The pathophysiology of DME includes multiple growth factors such as VEGF and also inflammatory mediators.
Thomas A Ciulla, Alon Harris
exaly +4 more sources
INTRAVITREAL FLUOCINOLONE ACETONIDE IMPLANT FOR RADIATION RETINOPATHY
Retina, 2023Purpose: To assess the efficacy of a 0.18 mg intravitreal fluocinolone acetonide (FA) implant (Yutiq, EyePoint Pharmaceuticals, Watertown, MA) as a treatment option for patients with radiation retinopathy-related cystoid macular edema.
Janani, Singaravelu +3 more
openaire +2 more sources
ANTERIOR MIGRATION OF INTRAVITREAL FLUOCINOLONE ACETONIDE IMPLANTS: A CASE REPORT
RETINAL Cases & Brief Reports, 2022Background/Purpose: To describe management of anterior migration of a fluocinolone acetonide(FAc) intravitreal implant. Methods: A retrospective case report. A 61-year-old man with diabetic macular edema and prior vitrectomy had anterior migration of a FAc implant.
Robert C, Gunzenhauser +2 more
openaire +2 more sources
Efficacy of the Fluocinolone Acetonide (Yutiq) Intravitreal Implant as Monotherapy for Uveitis
Ocular Immunology and Inflammation, 2022To evaluate the efficacy of the fluocinolone acetonide intravitreal implant (Yutiq) as monotherapy for uveitis.Retrospective cohort study.Patients at a single academic health-care institution.Medical record review of patients with non-infectious uveitis actively suppressed on an alternative anti-inflammatory regimen who received a fluocinolone ...
Hamidah Mahmud +3 more
openaire +2 more sources
Hypotony Maculopathy Associated With Extruded Fluocinolone Acetonide Intravitreal Implant
JAMA Ophthalmology, 2023This case report discusses a diagnosis of hypotony maculopathy associated with extrusion of a fluocinolone intravitreal implant in a patient who presented with painless, decreased vision in the right eye.
Matias, Soifer +2 more
openaire +2 more sources
Treatment of Serpiginous Choroiditis with Intravitreous Fluocinolone Acetonide Implant
Ocular Immunology and Inflammation, 2008To describe a case in which a fluocinolone acetonide implant was used in a patient with serpiginous choroiditis.Case report.A 57-year-old woman with active serpiginous choroiditis threatening the fovea of her right eye received one intravitreous triamcinolone acetonide injection, leading to immediate disease control.
Rajeev K, Seth, Paul A, Gaudio
openaire +2 more sources
Ophthalmology Retina, 2023
To report the outcomes of the 0.18-mg fluocinolone acetonide implant (FAi) in the treatment of noninfectious uveitis.Retrospective cohort study.Patients who received the 0.18-mg FAi for the treatment of noninfectious uveitis affecting the posterior segment (NIU-PS) between July 1, 2019, and August 31, 2021, at the University of Colorado.
Amit K, Reddy +3 more
openaire +2 more sources
To report the outcomes of the 0.18-mg fluocinolone acetonide implant (FAi) in the treatment of noninfectious uveitis.Retrospective cohort study.Patients who received the 0.18-mg FAi for the treatment of noninfectious uveitis affecting the posterior segment (NIU-PS) between July 1, 2019, and August 31, 2021, at the University of Colorado.
Amit K, Reddy +3 more
openaire +2 more sources
Fluocinolone Acetonide Intravitreal Implant (Iluvien®)
Drugs, 2013Fluocinolone acetonide intravitreal implant (Iluvien®) is an injectable, non-erodible, corticosteroid implant that is approved in several European countries for the treatment of chronic diabetic macular oedema (DMO). In analyses of two multinational trials in patients with DMO previously treated with macular laser photocoagulation, fluocinolone ...
openaire +2 more sources
Journal of Ocular Pharmacology and Therapeutics, 2013
To evaluate the efficacy and safety of the fluocinolone acetonide (Retisert) implant compared with the dexamethasone (Ozurdex) implant in patients with noninfectious uveitis.Comparative case series.Twenty-seven eyes received either the fluocinolone acetonide (FA) (n=16) or dexamethasone (n=11) implant.Chart review of patients at the Massachusetts Eye ...
Cheryl A, Arcinue +2 more
openaire +2 more sources
To evaluate the efficacy and safety of the fluocinolone acetonide (Retisert) implant compared with the dexamethasone (Ozurdex) implant in patients with noninfectious uveitis.Comparative case series.Twenty-seven eyes received either the fluocinolone acetonide (FA) (n=16) or dexamethasone (n=11) implant.Chart review of patients at the Massachusetts Eye ...
Cheryl A, Arcinue +2 more
openaire +2 more sources
INTRAVITREAL 0.18-mg FLUOCINOLONE ACETONIDE IMPLANT FOR PEDIATRIC UVEITIS
RetinaPurpose: This study reports the outcomes of the 0.18-mg intravitreal fluocinolone acetonide implant in the treatment of pediatric noninfectious uveitis. Methods: A retrospective cohort study was performed on patients under 18 years old who received fluocinolone acetonide implant ...
Stephanie Wangyu +4 more
openaire +2 more sources